Results

Total Results: 28 records

Showing results for "venous thromboembolism".
Users also searched for: vte

1. Chemoprevention of Breast Cancer - Recommendations and Rationale (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/MnkNvteY4Yg_8Jut4SayVN
   July 02, 2002 - incidence between the tamoxifen and placebo groups in this age group.7 The relative risk increase in venous … thromboembolism from tamoxifen or raloxifene appears similar to the risk for venous thromboembolism

2. Final Research Plan: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hypertensive-disorders-pregnancy-screening
   September 02, 2021 - infarction Renal or hepatic injury/failure Pulmonary edema, adult respiratory distress syndrome Venous … thromboembolism (deep vein thrombosis/pulmonary embolism) Disseminated intravascular coagulation

3. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide_3.pdf
   September 01, 2019 - difference no difference Fractures Cataracts Endometrial Cancer (cancer of the uterus) Blood Clots (venous … thromboembolism events) * Only tamoxifen is approved for use in premenopausal women. ** Aromatase inhibitors

4. Medicines to Help Prevent Breast Cancer: Let's Talk About It (pdf file)
   www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/breast-cancer-risk-reduction-discussion-guide.pdf
   September 01, 2019 - difference no difference Fractures Cataracts Endometrial Cancer (cancer of the uterus) Blood Clots (venous … thromboembolism events) * Only tamoxifen is approved for use in premenopausal women. ** Aromatase inhibitors

5. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
   September 03, 2019 - Project; PE, pulmonary embolism; RR, risk ratio; RUTH, Raloxifene Use for the Heart; SE, standard error; VTE … , venous thromboembolism. a Numbers of events reduced for benefits or increased for harms vs comparator

6. Archived: Evidence Summary: Aspirin Use to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
   April 11, 2016 - Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med . 2012;367:1979-87. … Thromboembolism; bid = twice daily; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin … Thromboembolism; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin; CVD = cardiovascular … Thromboembolism; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin; CDPRG = Coronary … Thromboembolism; BMD = British Male Doctors; CVD = cardiovascular disease; DVT = deep venous thrombosis

7. Zvvry6Wa4Sgj-Ejb3Brcvy (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
   November 01, 2013 - Effects In general, women receiving medications for breast cancer risk reduction are less likely to have VTE … Women with a personal or family history of venous thromboembolism are at higher risk for these ad- verse

8. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
   May 06, 2002 - The relative risk increase in venous thromboembolism from tamoxifen or raloxifene does not appear to … Risk of venous thromboembolism in users of hormone replacement therapy.

9. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
   April 15, 2013 - Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention

10. Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Njxn2r3qtWKdBf2_VhS2Aw
    April 01, 2016 - Thromboembolism; bid = twice daily; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin … Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012;367:1979- 87. … Thromboembolism; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin; CVD = cardiovascular … Thromboembolism; BMD = British Male Doctors; CDPA = Coronary Drug Project Aspirin; CDPRG = Coronary … Thromboembolism; BMD = British Male Doctors; CVD = cardiovascular disease; DVT = deep venous thrombosis

11. Archived: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
    January 01, 1996 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 1996 January 01, 1996 Recommendations …

12. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - ) events, or stroke. 3 When compared with placebo, raloxifene was associated with 7 more cases of VTE … on the STAR trial, more harms were reported with tamoxifen compared with raloxifene: 4 more cases of VTE

13. Archived: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-june-2018
    June 26, 2018 - Health Initiative trial, the previous review found an increased rate of gallbladder events, stroke, and venous … thromboembolism with estrogen therapy, and an increased risk of urinary incontinence during 1 year of … invasive breast cancer, coronary heart disease, probable dementia, gallbladder events, stroke, and venous … thromboembolism compared with women taking placebo, and an increased risk of urinary incontinence during

14. Recommendation: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
    September 03, 2019 - ) events, or stroke. 3 When compared with placebo, raloxifene was associated with 7 more cases of VTE … on the STAR trial, more harms were reported with tamoxifen compared with raloxifene: 4 more cases of VTE

15. Archived: Osteoporosis: Screening, 2002 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2002
    September 17, 2002 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Osteoporosis: Screening, 2002 September 17, 2002 Recommendations made by the USPSTF are independent of the U.S. government. They s…

16. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3Kwu7j_WfCFQSnSzqrDWwt
    June 20, 2019 - CHD) events, or stroke.3 When compared with placebo, raloxifene was associated with 7 more cases of VTE … on the STAR trial, more harms were reported with tamoxifen compared with raloxifene: 4 more cases of VTE

17. Screening for Osteoporosis in Postmenopausal Women - Recommendations and Rationale (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/nnkwqkX-Nk6v3gsphVATUD
    September 01, 2002 - Screening for Osteoporosis in Postmenopausal Women - Recommendations and Rationale Summary of Recommendations • The U.S. Preventive Services Task Force (USPSTF) recommends that women aged 65 and older be screened routinely for osteoporosis. The USPSTF recommends that routine screening begin at age 60 for women at i…

18. Screening for Osteoporosis to Prevent Fractures: USPSTF Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ffNDS7ekxovstoCxxtLJVt
    February 13, 2018 - Initiative trial, the previous review found an increased rate of gall- bladder events, stroke, and venous … thromboembolism with estro- gen therapy, and an increased risk of urinary incontinence during 1 year

19. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
    September 15, 2005 - using estrogen Tamoxifen, 3573; placebo, 3566 50 Total 69 101 0.68 (0.50-0.92) VTE … using estrogen Tamoxifen, 6576; placebo, 6599 55 Total 124 244 0.51 (0.41-0.63) ** VTE … using estrogen Tamoxifen, 1238; placebo, 1233 70 Total 34 36 0.94 (0.59-1.49) ** VTE … using estrogen Tamoxifen, 2700; placebo, 2708 46 Total 19 22 0.87 (0.47-1.60) ** VTE … estrogen receptor; NA = not available; NS = not statistically significant; PE = pulmonary embolism; VTE

20. Archived: Carotid Artery Stenosis: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/carotid-artery-stenosis-screening-1996
    January 01, 1996 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Carotid Artery Stenosis: Screening, 1996 January 01, 1996 Recommendations made by the USPSTF are independent of the U.S. governm…